z-logo
open-access-imgOpen Access
To Determine the Frequency of Thrombocytopenia in Pre Eclamptic Presented at Isra University Hospital
Author(s) -
Hafiza Khatoon,
Rukhsana Ahmed,
Arab Naz,
Nousheen Mushtaq,
Asma Irfan,
- Safia
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i50a33402
Subject(s) - medicine , preeclampsia , gestational age , university hospital , context (archaeology) , parity (physics) , obstetrics , cross sectional study , pediatrics , eclampsia , pregnancy , paleontology , genetics , physics , particle physics , pathology , biology
Objective: To determine the frequency of thrombocytopenia in pre-eclamptic women presented at Isra University Hospital Hyderabad. Patients and Methods: This cross sectional descriptive study of six months study was conducted at Isra university hospital from April 2019 to September 2019. All the patients between ≥18 - 45 years of age diagnosed preeclampsia were admitted and evaluated for thrombocytopenia. Results: During six month study period, total of 177 patients with preeclampsia were evaluated for thrombocytopenia. The majority of patients were from urban areas 125/177 (70.6%). The mean ±SD for maternal and gestational age of the preeclamptic patient was 32.75±8.85 and 28.75±7.63 whereas the mean platelet count was 93200±10.74 respectively. The majority of the patients were 21-30 years of age (54.8%) and the finding was statistically significant with gestational age [p=0.002]. The thrombocytopenia was observed in 99/177 (55.9%) and is statistically with relation to maternal age, gestational age and parity while in context to gravida and duration of disease it is non significant. Conclusion: A significantly high frequency of thrombocytopenia (55.9%) was recorded in the patients with preeclampsia and is statistically with relation to maternal and gestational age and parity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here